Fibulin, a novel protein that interacts with the fibronectin receptor beta subunit cytoplasmic domain.
about
Amino acid sequence of a novel integrin beta 4 subunit and primary expression of the mRNA in epithelial cellsAn interaction between alpha-actinin and the beta 1 integrin subunit in vitroA novel intracellular fibulin-1D variant binds to the cytoplasmic domain of integrin beta 1 subunitThe interaction of fibulin-1 with fibrinogen. A potential role in hemostasis and thrombosisThe self-association and fibronectin-binding sites of fibulin-1 map to calcium-binding epidermal growth factor-like domainsFibulin is an extracellular matrix and plasma glycoprotein with repeated domain structureCloning, primary structure and properties of a novel human integrin beta subunitCloning and sequence analysis of beta-4 cDNA: an integrin subunit that contains a unique 118 kd cytoplasmic domainStructure and expression of fibulin-2, a novel extracellular matrix protein with multiple EGF-like repeats and consensus motifs for calcium bindingHuman smooth muscle VLA-1 integrin: purification, substrate specificity, localization in aorta, and expression during developmentFibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1Chondrocyte expressed protein-68 (CEP-68), a novel human marker gene for cultured chondrocytes.Estrogens increase the expression of fibulin-1, an extracellular matrix protein secreted by human ovarian cancer cellsProteomic analysis of human serum for finding pathogenic factors and potential biomarkers in preeclampsiaUnraveling the mechanism of elastic fiber assembly: The roles of short fibulinsVacuoliting megalencephalic leukoencephalopathy with subcortical cysts, mapped to chromosome 22qtel.Fibulin-4 and fibulin-5 in elastogenesis and beyond: Insights from mouse and human studies.Fibulins: physiological and disease perspectives.Sequence of extracellular mouse protein BM-90/fibulin and its calcium-dependent binding to other basement-membrane ligands.Expression of fibulin-1 predicted good prognosis in patients with colorectal cancerCatheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction.Hemicentin 2 and Fibulin 1 are required for epidermal-dermal junction formation and fin mesenchymal cell migration during zebrafish development.Activation-dependent redistribution of the adhesion plaque protein, talin, in intact human platelets.Inhibition of binding of fibronectin to matrix assembly sites by anti-integrin (alpha 5 beta 1) antibodies.Fibulin-1 is required during cardiac ventricular morphogenesis for versican cleavage, suppression of ErbB2 and Erk1/2 activation, and to attenuate trabecular cardiomyocyte proliferationFibulin-5 function during tumorigenesis.Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes.Fibulin-1 purification from human plasma using affinity chromatography on Factor H-SepharoseMapping of the functional determinants of the integrin beta 1 cytoplasmic domain by site-directed mutagenesis.Mapping and topographic localization of epitopes of the Yersinia pseudotuberculosis invasin proteinSpecific structure and unique function define the hemicentin.TM14 is a new member of the fibulin family (fibulin-7) that interacts with extracellular matrix molecules and is active for cell binding.Expression of extracellular matrix proteins fibulin-1 and fibulin-2 by human corneal fibroblasts.Identification of the integrin binding domain of the Yersinia pseudotuberculosis invasin protein.Insider trading: Extracellular matrix proteins and their non-canonical intracellular roles.Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells.Fibulin's organization into the extracellular matrix of fetal lung fibroblasts is dependent on fibronectin matrix assembly.Characterization of a novel calcium-binding 90-kDa glycoprotein (BM-90) shared by basement membranes and serum.Molecular heterogeneity: a clinical dilemma. Clinical heterogeneity: a molecular dilemma.Identification of genes with differential regulation in primate endometrium during the proliferative and secretory phases of the cycle.
P2860
Q24302158-E70DCCA2-B98F-47D7-B6FC-236637D354ACQ24317203-62627BBF-D738-496D-978C-475FD13D425CQ24318286-E285BFC7-F3DC-4521-ADA0-10322D3385E9Q24323335-9D7B1ED2-58E1-4874-8607-A21AF2F43EC0Q24336713-72BE1981-E250-45CE-BFDC-EB939B076BD3Q24338248-E47971CA-2ECC-42D1-9A32-4F5CFB7CB376Q24556549-795BF824-FB8C-40DB-BCA9-A4B89659A9FBQ24556558-4E6E87C5-4CB2-4D0B-88E2-6650C9680626Q24673741-0629F463-969F-4C23-8365-8B0DB8A1A9D5Q24678731-93570F6E-D076-4CD2-9C24-678ECB744559Q28586832-AB7AAC28-BAA2-4A16-BA18-7386AB656D50Q30622896-17AB18AC-D161-4CE7-BBC6-7B1AF68D2304Q33619562-FC84F7D3-BC00-4CD9-B1C4-1E08D5D1D51EQ33767249-BC822972-5E30-49CE-AD27-97A1F38617C3Q33891925-FA90BBEA-357F-479E-AB6A-4D8FD16C81C9Q34145226-3C9C66C6-7BD2-4EA4-BB0B-EFAAA81B5020Q34145642-4D2E12F6-F1BE-4745-80E0-75A69CFD084CQ34250587-870DF934-B6C6-4FB2-A96C-AA9912A853BEQ34353058-E18A69A4-299E-4728-BFDF-CC9FF2CA2B54Q35453523-0CC0A540-A90A-41C6-8283-1CAFFAC7220FQ35774342-C660051C-1D19-4966-90E5-3B1578005440Q36177110-AAA0075B-D011-4DCD-B5BD-F50C31A118B0Q36222072-083D4E3C-B627-4717-A74F-609238CB8AA4Q36223428-D8A9E161-EC2A-4445-A29E-0C2E17E36ED5Q36371834-29F52D3D-C2B2-4085-9298-E3AB91AC0C74Q36429377-1B33CA71-CFEB-410E-A5A6-798CA1F32B7AQ36604574-483DD695-197E-4FBF-BED8-F521D98F9ECBQ36717079-D5BD76F0-82E5-4D17-A223-5EC63A42164DQ36738965-9E0C3549-0DE2-4AFE-BEFA-805218E9F541Q36987647-D935286A-EF4F-4C42-A84E-23F3DC37D90EQ37000948-B2A915AD-25C8-4349-94E0-70876EA323A8Q38299179-F11114A2-FCB3-41A5-AFC8-2886A2399BDCQ38300270-D7276297-749A-42AA-AF2A-7D2BA153ECE6Q38340751-EFA55D62-7E18-478C-847B-685BB843BE86Q38688202-ED7B8B05-2515-48E2-BC1E-6442FD7DDD0AQ40750156-1BEB6730-D66A-422A-A22F-560BE778C805Q41555534-19D9351D-2AEC-412D-A77F-4C8EBACAD7E1Q42634754-B40548AC-BEB2-48C8-96E8-AFE286F59034Q43147080-9D67C2A5-9823-405E-B3B8-4977CCC64FA8Q44382727-613DA5DD-B13E-42D8-949E-155DAC6D1FA4
P2860
Fibulin, a novel protein that interacts with the fibronectin receptor beta subunit cytoplasmic domain.
description
1989 nî lūn-bûn
@nan
1989 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Fibulin, a novel protein that ...... ta subunit cytoplasmic domain.
@ast
Fibulin, a novel protein that ...... ta subunit cytoplasmic domain.
@en
Fibulin, a novel protein that ...... ta subunit cytoplasmic domain.
@nl
type
label
Fibulin, a novel protein that ...... ta subunit cytoplasmic domain.
@ast
Fibulin, a novel protein that ...... ta subunit cytoplasmic domain.
@en
Fibulin, a novel protein that ...... ta subunit cytoplasmic domain.
@nl
prefLabel
Fibulin, a novel protein that ...... ta subunit cytoplasmic domain.
@ast
Fibulin, a novel protein that ...... ta subunit cytoplasmic domain.
@en
Fibulin, a novel protein that ...... ta subunit cytoplasmic domain.
@nl
P2093
P1433
P1476
Fibulin, a novel protein that ...... ta subunit cytoplasmic domain.
@en
P2093
Argraves WS
Burgess WH
Dickerson K
Ruoslahti E
P304
P356
10.1016/0092-8674(89)90097-4
P407
P577
1989-08-01T00:00:00Z